Anheuser-Busch InBev SA/NV
Anheuser-Busch InBev SA/NV (BUDFF) Financial Performance & Income Statement Overview
Explore the financials of Anheuser-Busch InBev SA/NV (BUDFF), including yearly and quarterly data on income, cash flow, and balance sheets.
Anheuser-Busch InBev SA/NV (BUDFF) Income Statement & Financial Overview
Review Anheuser-Busch InBev SA/NV BUDFF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $13.63B | $14.84B | $15.05B | $15.33B |
| Cost of Revenue | $6.04B | $6.64B | $6.68B | $6.77B |
| Gross Profit | $7.58B | $8.20B | $8.37B | $8.57B |
| Gross Profit Ratio | $0.56 | $0.55 | $0.56 | $0.56 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.19B | $4.60B | $4.49B | $4.81B |
| Operating Expenses | $4.00B | $4.35B | $4.28B | $4.66B |
| Total Costs & Expenses | $10.04B | $10.99B | $10.96B | $11.43B |
| Interest Income | $30.00M | $638.00M | -$152.63M | $25.00M |
| Interest Expense | $818.00M | $1.35B | $792.12M | $960.00M |
| Depreciation & Amortization | $0.00 | $0.00 | $61.00M | -$221.00M |
| EBITDA | $4.03B | $4.00B | $5.03B | $3.68B |
| EBITDA Ratio | $0.30 | $0.27 | $0.33 | $0.24 |
| Operating Income | $3.59B | $3.85B | $4.09B | $3.90B |
| Operating Income Ratio | $0.26 | $0.26 | $0.27 | $0.25 |
| Other Income/Expenses (Net) | -$379.00M | -$1.31B | -$843.00M | -$1.40B |
| Income Before Tax | $3.21B | $2.54B | $3.25B | $2.50B |
| Income Before Tax Ratio | $0.24 | $0.17 | $0.22 | $0.16 |
| Income Tax Expense | $664.00M | $848.00M | $758.00M | $752.00M |
| Net Income | $2.15B | $1.22B | $2.07B | $1.47B |
| Net Income Ratio | $0.16 | $0.08 | $0.14 | $0.10 |
| EPS | $1.08 | $0.61 | $1.03 | $1.18 |
| Diluted EPS | $1.08 | $0.60 | $1.03 | $1.16 |
| Weighted Avg Shares Outstanding | $1.99B | $2.005B | $2.005B | $2.005B |
| Weighted Avg Shares Outstanding (Diluted) | $1.99B | $2.04B | $2.04B | $2.04B |
Financial performance has remained strong, with revenue growing from $15.33B in Q2 2024 to $13.63B in Q1 2025. Gross profit continued to perform well, with margins at 56% in the latest quarter. Operating income reached $3.59B in Q1 2025, holding a steady 26% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $4.03B. Net income rose to $2.15B, keeping EPS at $1.08. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan